COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 581: Articles 5801-5810  | Next

Effect of Ivermectin 600 mcg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial
Naggie, S., Boulware, D. R., Lindsell, C. J., Stewart, T. G., Lim, S. C., Cohen, J., Kavtaradze, D., Amon, A. P., Gabriel, A., Gentile, N., Felker, G. M., Rothman, R. L., Jayaweera, D., McCarthy, M. W., Sulkowski, M., Wilson, S., DeLong, A., Remaly, A., Wilder, R., Collins, S., Dunsmore, S. E., Adam, S. J., Thicklin, F., Hanna, G., Ginde, A. A., Castro, M., McTigue, K., Shenkman, E., Hernandez, A. F.
10.1101/2022.12.15.22283488 — Posted: 2022-12-15
The estimated disease burden of COVID-19 in Japan from 2020 to 2021
Tsuzuki, S., Beutels, P.
10.1101/2022.12.14.22283492 — Posted: 2022-12-15
SARS-CoV-2 causes periodontal fibrosis by deregulating mitochondrial beta-oxidation
Gao, Y., Kok, W. L., Sharma, V., Illsley, C. S., Hanks, S., Tredwin, C., Hu, B.
10.1101/2022.12.15.520561 — Posted: 2022-12-15
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T-cell recognition epitopes
Muik, A., Lui, B. G., Diao, H., Fu, Y., Bacher, M., Toker, A., Grosser, J., Ozhelvaci, O., Grikscheit, K., Hoehl, S., Kohmer, N., Lustig, Y., Regev-Yochay, G., Ciesek, S., Beguir, K., Poran, A., Tuereci, O., Sahin, U.
10.1101/2022.12.15.520569 — Posted: 2022-12-15
Crowdsourcing Temporal Transcriptomic Coronavirus Host Infection Data: resources, guide, and novel insights.
Flynn, J., Ahmadi, M., McFarland, C., Kubal, M., Taylor, M., Cheng, Z., Torchia, E. C., Edwards, M.
10.1101/2022.12.14.520483 — Posted: 2022-12-15
Understanding the mechanism of the SARS CoV-2 coinfection with other respiratory viruses
Ponnusamy, K., Srinivasan, R. V., Marwal, R., Datta, M., Dhar, M. S., Chaudhary, U., Sharma, U., Kumari, S., Sharma, K., Gogia, H., Madan, P., Kabra, S., Rakshit, P.
10.1101/2022.12.15.520197 — Posted: 2022-12-15
Long-term neutralizing antibody dynamics against SARS-CoV-2 in symptomatic and asymptomatic infections: a systematic review and meta-analysis
Lu, W., Zheng, N., Chen, X., Sun, R., Dong, J., Ge, S., Deng, X., Yu, H.
10.1101/2022.12.15.22283503 — Posted: 2022-12-15
COVID-19 Associated Pulmonary Aspergillosis isolates are genomically diverse but similar to each other in their responses to infection-relevant stresses
Mead, M. E., Alves de Castro, P., Steenwyk, J. B., Gangneux, J.-P., Hoenigl, M., Prattes, J., Rautemaa-Richardson, R., Guegan, H., Moore, C. B., Lass-Floerl, C., Reizine, F., Valero, C., van Rhijn, N., Bromley, M. J., Rokas, A., Goldman, G. H., Gago, S.
10.1101/2022.12.14.520265 — Posted: 2022-12-15
Milk antibody response after 3rd dose of COVID-19 mRNA vaccine and SARS-CoV-2 breakthrough infection and implications for infant protection
Golan, Y., Ilala, M., Gay, C., Hunagund, S., Lin, C. Y., Cassidy, A. G., Jigmeddagva, U., Li, L., Ozarslan, N., Asiodu, I. V., Ahituv, N., Flaherman, V. J., Gaw, S. L., Prahl, M.
10.1101/2022.12.12.22283367 — Posted: 2022-12-14
Vendors' perceptions on the bushmeat trade dynamics across West Africa during the COVID-19 pandemic: lessons learned on sanitary measures and awareness campaigns
Gaubert, P., Djagoun, C. A. M. S., Missoup, A. D., Ales, N., Amougou, C. V., Dipita, A. D., Djagoun, J., Gosse, K. J., Koffi, C. E., N'Goran, E. M., Noma, Y. N., Zanvo, S., Tindo, M., Antunes, A., Gonedele Bi, S.
10.1101/2022.12.12.22283285 — Posted: 2022-12-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).